---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-296035"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2022-12-01T23:59:59+00:00"
generated_at: "2026-06-21T11:14:30.752900+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD extends debt maturity to Dec 31, 2022; pays $4.2M accrued interest and $750K fee

## Summary
- Amendment No. 17 extends Financing Agreement maturity to Dec 31, 2022, contingent on certain milestones.
- Minimum cash covenant set at $7.5M; amendment fee of $750,000 paid to lenders.
- Company paid approximately $4.2M in accrued and unpaid interest as of Nov 30, 2022.
- Board continues evaluating options to strengthen capital structure and maintain normal operations.
- Company faces going-concern risk if it cannot refinance or raise additional capital.

## SEC filing metadata
- accession: 0001193125-22-296035
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2022-12-01T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000119312522296035/0001193125-22-296035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000119312522296035/d404005d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-296035
- JSON: https://secwatch.observer/filing/0001193125-22-296035.json
- Plain text: https://secwatch.observer/filing/0001193125-22-296035.txt

## Key facts
- Material Agreements
  TherapeuticsMD, Inc. amended Amendment No. 17 with Sixth Street Specialty Lending, Inc., as administrative agent, the various lenders from time to time party thereto (the “Lenders”) valued at amendment fee in the amount of $750,000 (effective 2022-11-30).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: Sixth Street Specialty Lending, Inc., as administrative agent, the various lenders from time to time party thereto (the “Lenders”)
  - Value: amendment fee in the amount of $750,000
  - Effective: 2022-11-30
  source text: On November 30, 2022 (the “Amendment Date”), TherapeuticsMD, Inc., a Nevada corporation (the “Company”), entered into Amendment No. 17 (“Amendment No. 17”) to that certain Financing Agreement, dated as of April 24, 2019, as amended, with Sixth Street Specialty Lending, Inc., as administrative agent, the various lenders from time to time party thereto (the “Lenders”), and certain of the Company’s subsidiaries party thereto from time to time as guarantors (the “Financing Agreement”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/25743/000119312522296035/0001193125-22-296035-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.